Eva Vohlídalová

Eva Vohlídalová

Auto-generated profile, based on publicly available information

Eva Vohlídalová

Department of Pharmacology, Faculty of Medicine, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Journal of Controlled Release
Verified
Journal Article
Closed access
EMEliška Mašková
Eliška Mašková
KKKaterina Kubova
Katerina Kubova
BRBahijja T. Raimi-Abraham
Bahijja T. Raimi-Abraham
Driton VllasaliuDriton Vllasaliu
Driton Vllasaliu
EVEva Vohlídalová
Eva Vohlídalová
JMJosef Mašek
Josef Mašek

11 April 2020 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
GDGuilherme Dragunas
Guilherme Dragunas
MWManon E. Woest
Manon E. Woest
SNSusan Nijboer
Susan Nijboer
SBSophie T. Bos
Sophie T. Bos
JAJanet van Asselt
Janet van Asselt
LKLoes E. M. Kistemaker
Loes E. M. Kistemaker
Parasympathetic neurons in the airways control bronchomotor tone. Increased activity of cholinergic neurons are mediators of airway hyperresponsiveness (AHR) in asthma, however, mechanisms are not elucidated. We describe remodeling of the cholinergic neuronal network in asthmatic airways driven by brain‐derived neurotrophic factor (BDNF) and Tropomyosin receptor kinase B ( TrkB). Human bronchial biopsies were stained for cholinergic marker vesicular acetylcholine transporter (VAChT). Human lung gene expression and single nucleotide polymorphisms (SNP) in neuroplasticity‐related genes were compared between asthma and healthy patients. Wild‐type (WT) and mutated TrkB knock‐in mice (Ntrk2tm1Ddg/J) with impaired BDNF signaling were chronically exposed to ovalbumin (OVA). Neuronal VAChT staining and airway narrowing in response to electrical field stimulation in precision cut lung slices (PCLS) were assessed. Increased cholinergic fibers in asthmatic airway biopsies was found, paralleled by increased TrkB gene expression in human lung tissue, and SNPs in the NTRK2 [TrkB] and BDNF genes linked to asthma. Chronic allergen exposure in mice resulted in increased density of cholinergic nerves, which was prevented by inhibiting TrkB. Increased nerve density resulted in AHR in vivo and in increased nerve‐dependent airway reactivity in lung slices mediated via TrkB. These findings show cholinergic neuroplasticity in asthma driven by TrkB signaling and suggest that the BDNF‐TrkB pathway may be a potential target.

2 December 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
HPHana Petroková
Hana Petroková
JMJosef Mašek
Josef Mašek
MKMilan Kuchař
Milan Kuchař
AWAndrea Viteckova Wunschova
Andrea Viteckova Wunschova
JŠJana Štikarová
Jana Štikarová
JTJaroslav Turanek
Jaroslav Turanek
Development of tools for direct thrombus imaging represents a key step for diagnosis and treatment of stroke. Nanoliposomal carriers of contrast agents and thrombolytics can be functionalized to target blood thrombi by small protein binders with selectivity for fibrin domains uniquely formed on insoluble fibrin. We employed a highly complex combinatorial library derived from scaffold of 46 amino acid albumin-binding domain (ABD) of streptococcal protein G, and ribosome display, to identify variants recognizing fibrin cloth in human thrombus. We constructed a recombinant target as a stretch of three identical fibrin fragments of 16 amino acid peptide of the Bβ chain fused to TolA protein. Ribosome display selection followed by large-scale Enzyme-Linked ImmunoSorbent Assay (ELISA) screening provided four protein variants preferentially binding to insoluble form of human fibrin. The most specific binder variant D7 was further modified by C-terminal FLAG/His-Tag or double His-tag for the attachment onto the surface of nanoliposomes via metallochelating bond. D7-His-nanoliposomes were tested using in vitro flow model of coronary artery and their binding to fibrin fibers was demonstrated by confocal and electron microscopy. Thus, we present here the concept of fibrin-targeted binders as a platform for functionalization of nanoliposomes in the development of advanced imaging tools and future theranostics.

15 February 2024 in ACS Omega
Verified
Journal Article
Open access
VBVeronika Brezani
Veronika Brezani
NBNicolas Blondeau
Nicolas Blondeau
JKJan Kotouček
Jan Kotouček
EKEva Klásková
Eva Klásková
KŠKarel Šmejkal
Karel Šmejkal
JMJosef Mašek
Josef Mašek
Stilbenes in food and medicinal plants have been described as potent antiphlogistic and antioxidant compounds, and therefore, they present an interesting potential for the development of dietary supplements. Among them, macasiamenene F (MF) has recently been shown to be an effective anti-inflammatory and cytoprotective agent that dampens peripheral and CNS inflammation in vitro. Nevertheless, this promising molecule, like other stilbenes and a large percentage of drugs under development, faces poor water solubility, which results in trickier in vivo administration and low bioavailability. With the aim of improving MF solubility and developing a form optimized for in vivo administration, eight types of conventional liposomal nanocarriers and one type of PEGylated liposomes were formulated and characterized. In order to select the appropriate form of MF encapsulation, the safety of MF liposomal formulations was evaluated on THP-1 and THP-1-XBlue-MD2-CD14 monocytes, BV-2 microglia, and primary cortical neurons in culture. Furthermore, the cellular uptake of liposomes and the effect of encapsulation on MF anti-inflammatory effectiveness were evaluated on THP-1-XBlue-MD2-CD14 monocytes and BV-2 microglia. MF (5 mol %) encapsulated in PEGylated liposomes with an average size of 160 nm and polydispersity index of 0.122 was stable, safe, and the most promising form of MF encapsulation keeping its cytoprotective and anti-inflammatory properties.

11 March 2026 in Pharmacological Reports
Verified
Journal Article
Open access
EKEva Klaskova
Eva Klaskova
JJJan Juřica
Jan Juřica
Przemysław Jan DanekPrzemysław Jan Danek
Przemysław Jan Danek
NMNatalie Mlcuchova
Natalie Mlcuchova
SESaltuk Mustafa Eyrilmez
Saltuk Mustafa Eyrilmez
OZOndrej Zendulka
Ondrej Zendulka
Salidroside (SAL) is the active ingredient of the traditional adaptogenic herb Rhodiola rosea. Cytochromes P450 (P450), crucial enzymes in drug metabolism, are central to understanding drug–herb interactions. This study investigates the impact of SAL on the metabolic activity of selected P450 in both rat and human systems. Wistar rats were administered intragastrically with SAL 5, 15, or 45 mg/kg/day for seven days. The metabolic activity of CYP1A2, CYP2C6, CYP2D, and CYP3A was measured in rat liver microsomes (RLMs). Amounts and gene expressions of CYP1A2 and CYP2C6 were assessed in RLMs using Western blot and two-step qRT-PCR. rPXR, hPXR, and CAR3 gene reporter assays were conducted. The in vitro inhibitory studies of SAL in both drug-naïve rat and human liver microsomes were performed. Interactions between SAL and human P450 were also studied by in silico methods. SAL at the dose of 5 mg/kg/day slightly increased the specific activity of the P450 studied. However, SAL did not change either the P450 protein levels or the expression of the corresponding genes in rat liver. It also did not cause direct inhibition of rat and human P450 in liver microsomes in vitro. Molecular docking with human P450 confirmed these findings. Moreover, SAL inhibited the agonist-mediated induction of both rat and human PXR. Based on our findings, SAL is unlikely to pose a significant risk of P450-mediated drug-herb interactions and rather preserves the constitutional CYP3A metabolic activity via interaction with PXR. Not applicable. The online version contains supplementary material available at 10.1007/s43440-026-00842-w.